A systematic review of treatments for hidradenitis suppurativa

Archives of Dermatology

Volumn 148, Issue 4, 2012, Pages 439-446

  Rambhatla, Pranita V ^a   Lim, Henry W ^a   Hamzavi, Iltefat ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIANDROGEN; ANTIBIOTIC AGENT; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; COLLAGEN SPONGE; DAPSONE; EFALIZUMAB; ETANERCEPT; ETRETIN; FINASTERIDE; GENTAMICIN; GLUCONATE ZINC; INFLIXIMAB; ISOTRETINOIN; MINOCYCLINE; PLACEBO; RESORCINOL; RIFAMPICIN; TETRACYCLINE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; CARBON DIOXIDE LASER; CHEILITIS; CLINICAL EFFECTIVENESS; CRYOTHERAPY; DEPRESSION; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EAR DISEASE; FATIGUE; GASTROINTESTINAL SYMPTOM; HEALING; HORMONAL THERAPY; HUMAN; HYPERTRICHOSIS; INFUSION SITE REACTION; LASER SURGERY; LUPUS VULGARIS; MAINTENANCE THERAPY; MONOTHERAPY; MOTOR NEUROPATHY; NAUSEA; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; REVIEW; SKIN DISEASE; SUPPURATIVE HIDRADENITIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; BIOLOGICAL AGENTS; CLINDAMYCIN; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; HIDRADENITIS SUPPURATIVA; HUMANS; LASERS, SOLID-STATE; RIFAMPIN;

EID: 84859980707     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.1950     Document Type: Review

References (72)

1. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596-601.
2. 2 laser stripping-secondary intention technique. Br J Dermatol. 1994;131(4):551-556.
3. Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. 2002;47(2):280-285.
4. Robinson JK, Dellavalle RP, Bigby M, Callen JP. Systematic reviews: grading recommendations and evidence quality. Arch Dermatol. 2008;144(1):97-99. (Pubitemid 351159395)
5. Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154(5):977-978.
6. Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219(2):148-154.
7. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149(1):211-213. (Pubitemid 36966545)
8. van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology. 2009;219(2):143-147.
9. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40(1): 73-76. (Pubitemid 29051027)
10. Soria A, Canoui-Poitrine F, Wolkenstein P, et al. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment. Dermatology. 2009;218(2):134-135.
11. Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatolog Treat. 2006;17(4):211-213. (Pubitemid 44395545)
12. Kraft JN, Searles GE. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg. 2007;11(4):125-131.
13. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39(6): 971-974. (Pubitemid 28547731)
14. Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol. 2003;149(5):1046-1049. (Pubitemid 37541993)
15. Fernández-Vozmediano JM, Armario-Hita JC. Infliximab for the treatment of hidradenitis suppurativa. Dermatology. 2007;215(1):41-44. (Pubitemid 46976013)
16. Fardet L, Dupuy A, Kerob D, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol. 2007; 56(4):624-628. (Pubitemid 46400174)
17. Usmani N, Clayton TH, Everett S, Goodfield MD. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol. 2007;32 (2):204-205. (Pubitemid 46233031)
18. Mekkes JR, Bos JD. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol. 2008;158(2):370-374.
19. Brunasso AM, Delfino C, Massone C. Hidradenitis suppurativa: are tumour necrosis factor-α blockers the ultimate alternative? Br J Dermatol. 2008;159(3): 761-763.
20. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, doubleblind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62(2): 205-217.
21. Adams DR, Yankura JA, Fogelberg AC, Anderson BE. Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol. 2010;146(5):501-504.
22. Pelekanou A, Kanni T, Savva A, et al. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial. Exp Dermatol. 2009;19(6):538-540.
23. Lee RA, Dommasch E, Treat J, et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2009; 60(4):565-573.
24. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol. 2008;158(3):567-572. (Pubitemid 351239170)
25. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154(4):726-729. (Pubitemid 43374099)
26. Sotiriou E, Apalla Z, Ioannidos D. Etanercept for the treatment of hidradenitis suppurativa. Acta Derm Venereol. 2009;89(1):82-83.
27. Blanco R, Martínez-Taboada VM, Villa I, et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol. 2009;145 (5):580-584.
28. Amano M, Grant A, Kerdel FA. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. Int J Dermatol. 2010; 49(8):950-955.
29. Strober BE, Kim C, Siu K. Efalizumab for the treatment of refractory hidradenitis suppurativa. J Am Acad Dermatol. 2007;57(6):1090-1091. (Pubitemid 350087344)
30. Roenigk RK, Roenigk HH. Roenigk & Roenigk's Dermatologic Surgery: Principles and Practice. 2nd ed. New York, NY: M. Dekker; 1996.
31. Finley EM, Ratz JL. Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing. J Am Acad Dermatol. 1996;34 (3):465-469. (Pubitemid 26083826)
32. Madan V, Hindle E, Hussain W, August PJ. Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol. 2008;159(6):1309-1314.
33. Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36(2): 208-213.
34. Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2009;35(8):1188-1198.
35. Buimer MG, Ankersmit MF, Wobbes T, Klinkenbijl JH. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 2008;34(2):224-227.
36. van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475-480.
37. Bohn J, Svensson H. Surgical treatment of hidradenitis suppurativa. Scand J Plast Reconstr Surg Hand Surg. 2001;35(3):305-309. (Pubitemid 32928058)
38. Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26(7):638-643. (Pubitemid 30470626)
39. Ritz JP, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis. 1998;13(4):164-168. (Pubitemid 28444875)
40. Wiltz O, Schoetz DJ Jr, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa: the Lahey Clinic experience. Dis Colon Rectum. 1990;33(9):731-734. (Pubitemid 20308157)
41. Bieniek A, Matusiak L, Okulewicz-Gojlik D, Szepietowski JC. Surgical treatment of hidradenitis suppurativa: experiences and recommendations. Dermatol Surg. 2010;36(12):1998-2004.
42. Aksakal AB, Adişen E. Hidradenitis suppurativa: importance of early treatment: efficient treatment with electrosurgery. Dermatol Surg. 2008;34(2):228- 231.
43. Kagan RJ, Yakuboff KP, Warner P, Warden GD. Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery. 2005;138(4):734-741. (Pubitemid 41546196)
44. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SE. Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum. 2003;46(7):944-949. (Pubitemid 36875492)
45. Tanaka A, Hatoko M, Tada H, Kuwahara M, Mashiba K, Yurugi S. Experience with surgical treatment of hidradenitis suppurativa. Ann Plast Surg. 2001;47(6): 636-642. (Pubitemid 33131389)
46. Soldin MG, Tulley P, Kaplan H, Hudson DA, Grobbelaar AO. Chronic axillary hidradenitis: the efficacy of wide excision and flap coverage. Br J Plast Surg. 2000; 53(5):434-436. (Pubitemid 30479652)
47. Golcman R, Golcman B, Tamura BM, Nogueira MA, Zoo CM, Germano JA. Subcutaneous fistulectomy in bridging hidradenitis suppurativa. Dermatol Surg. 1999; 25(10):795-798. (Pubitemid 29480974)
48. Endo Y, Tamura A, Ishikawa O, Miyachi Y. Perianal hidradenitis suppurativa: early surgical treatment gives good results in chronic or recurrent cases. Br J Dermatol. 1998;139(5):906-910. (Pubitemid 28520306)
49. Rhode JM, Burke WM, Cederna PS, Haefner HK. Outcomes of surgical management of stage III vulvar hidradenitis suppurativa. J Reprod Med. 2008;53(6): 420-428. (Pubitemid 351976414)
50. Chuang CJ, Lee CH, Chen TM, Wang HJ, Chen SG. Use of a versatile transpositional flap in the surgical treatment of axillary hidradenitis suppurativa. J Formos Med Assoc. 2004;103(8):644-647. (Pubitemid 39480796)
51. Altmann S, Fansa H, Schneider W. Axillary hidradenitis suppurativa: a further option for surgical treatment. J Cutan Med Surg. 2004;8(1):6-10. (Pubitemid 38392020)
52. Geh JL, Niranjan NS. Perforator-based fasciocutaneous island flaps for the reconstruction of axillary defects following excision of hidradenitis suppurativa. Br J Plast Surg. 2002;55(2):124-128.
53. Schwabegger AH, Herczeg E, Piza H. The lateral thoracic fasciocutaneous island flap for treatment of recurrent hidradenitis axillaris suppurativa and other axillary skin defects. Br J Plast Surg. 2000;53(8):676-678.
54. Ortiz CL, Castillo VL, Pilarte FS, Barraguer EL. Experience using the thoracodorsal artery perforator flap in axillary hidradenitis suppurativa cases. Aesthetic Plast Surg. 2010;34(6):785-792.
55. Varkarakis G, Daniels J, Coker K, Oswald T, Akdemir O, Lineaweaver WC. Treatment of axillary hidradenitis with transposition flaps: a 6-year experience. Ann Plast Surg. 2010;64(5):592-594.
56. Mandal A, Watson J. Experience with different treatment modules in hidradenitis suppuritiva: a study of 106 cases. Surgeon. 2005;3(1):23-26. (Pubitemid 40259989)
57. Hynes PJ, Earley MJ, Lawlor D. Split-thickness skin grafts and negativepressure dressings in the treatment of axillary hidradenitis suppurativa. Br J Plast Surg. 2002;55(6):507-509.
58. Kuo HW, Ohara K. Surgical treatment of chronic gluteal hidradenitis suppurativa: reused skin graft technique. Dermatol Surg. 2003;29(2):173-178. (Pubitemid 36188427)
59. Bong JL, Shalders K, Saihan E. Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy. Clin Exp Dermatol. 2003;28(3):241- 244.
60. Gold M, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(1)(suppl):S32-S35.
61. Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol. 2005;152(4):803-804. (Pubitemid 40571321)
62. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat. 2005;16(2):75-78. (Pubitemid 40676905)
63. Brocard A, Knol AC, Khammari A, Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach: a pilot study. Dermatology. 2007;214(4):325-327. (Pubitemid 46659015)
64. Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36-40.
65. Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa: is acne inversa also a misnomer? Br J Dermatol. 2011;164(1):170-175.
66. Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology. 1996;193(3):203-206. (Pubitemid 26361521)
67. Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010; 62(4):706.e1-708.e1.
68. König A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198(3):261-264. (Pubitemid 29281414)
69. Sartorius K, Killasli H, Heilborn J, Jemec GB, Lapins J, Emtestam L. Interobserver variability of clinical scores in hidradenitis suppurativa is low. Br J Dermatol. 2010;162(6):1261-1268.
70. ClinicalTrials.gov. Study of adalimumab in subjects with moderate to severe chronic hidradenitis suppurativa. http://clinicaltrials.gov/ct2/show/ NCT00918255. Accessed July 21, 2010.
71. Trombetta M, Werts ED, Parda D. The role of radiotherapy in the treatment of hidradenitis suppurativa: case report and review of the literature. Dermatol Online J. 2010;16(2):e16 http://dermatology.cdlib.org/1602/letters/hs/trombetta .html. Accessed October 8, 2011.
72. Lasocki A, Sinclair R, Foley P, Saunders H. Hidradenitis suppurativa responding to treatment with infliximab. Australas J Dermatol. 2010;51(3):186-190.